Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P8
Near historical low
vs 5Y Ago
-1.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -26.37% |
| 2024 | -31.38% |
| 2023 | 10.30% |
| 2022 | 1.45% |
| 2021 | 125.06% |
| 2020 | 24.35% |
| 2019 | -24.08% |
| 2018 | -4.24% |
| 2017 | 4.37% |
| 2016 | 94.59% |